InsiderClue
Stocks · Health care · Pharmaceutical Preparations

FibroBiologics, Inc.

FBLG Clue Score47
United States Fiscal year ends December CIK 0001958777
$1.13 +1.80% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $1.13 +131.84% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 31 Jan 2024. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−4.5Net income−5.1EPS, diluted−0.18Fiscal year 2023Operating income−8.9Net income−16.5EPS, diluted−0.68Fiscal year 2024Operating income−13.7Net income−11.2EPS, diluted−0.34Fiscal year 2025Operating income−16.6Net income−18.6EPS, diluted−0.42
FY2022FY2023FY2024FY2025
Operating income −4.5 −8.9 −13.7 −16.6
Net income −5.1 −16.5 −11.2 −18.6
Growth
EPS, diluted −0.18 −0.68 −0.34 −0.42
Growth

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−4.1Fiscal year 2023Operating cash flow−6.4Capital expenditure−0.5Free cash flow−6.9Fiscal year 2024Operating cash flow−11.9Capital expenditure−0.2Free cash flow−12.1Fiscal year 2025Operating cash flow−16.4Capital expenditure−0.3Free cash flow−16.7
FY2022FY2023FY2024FY2025
Operating cash flow −4.1 −6.4 −11.9 −16.4
Capital expenditure n/a −0.5 −0.2 −0.3
Free cash flow n/a −6.9 −12.1 −16.7
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash2.3Shareholders’ equity−4.0Fiscal year 2023Cash9.2Shareholders’ equity1.3Fiscal year 2024Cash14.0Shareholders’ equity2.7Fiscal year 2025Cash4.9Shareholders’ equity6.2
FY2022FY2023FY2024FY2025
Cash 2.3 9.2 14.0 4.9
Shareholders’ equity −4.0 1.3 2.7 6.2

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Revenue and profit
1.1 2.4 4.5 7.4
3.3 6.5 9.2 9.2
−4.5 −8.9 −13.7 −16.6
Growth
0.0 0.0 0.0 0.0
−5.1 −16.5 −11.2 −18.6
Growth
Per share
−0.18 −0.68 −0.34 −0.42
−0.18 −0.68 −0.34 −0.42
Growth
28.2 28.2 32.9 44.7
28.2 28.2 32.9 44.7
Growth +0.0% +16.5% +35.8%

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 4 of 4 years on file.